1Mazoyer E, Prouet L,Soria S,et al.Risk factors and outcomes for atherothombotic disease in French patients: the RIVAGE study.Risque Vasculaire Group d' Etude [J]. Thromb Res. 1999,95 (4) :163-176.
2Anderson GM, Shaw AR, Shafer JA, et al. Functional characterization of promoter involved in regulation of Human B-fibrinogen expression [J]. J Biol Chem,1993,268(30):22650-22655.
3Cook DG,Caoouccio FP, Atkinson RW,et al. Ethnic differences in fibrinogen levels:the role of environmental factors and the beta-fibrinogen gene [J]. Am J Epidemiol, 2001,153(8) : 799-806.
4van' t Hooft FM,von Bahr SJ,Silveira A, et al. Two common, functional polymorphisms in the promoter region of the β-fibrinogen gene contribute to regulation of plasma fibrinogen concentration [J]. Arterioscler Thrornb Vasc Biol, 1999,19 (12) : 3063-3070.
5Tataru MC, Schuhe H, von Bckardstin A, et ah Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction [J]. Coron Artery Dis, 2001,12 (3) : 157-165.
6Labanti G,Urbinati S, Grepioni A,et al. Complicated atherosclerosis of the ascending aorta as a cause of recurrent cerebral embolisms in young adulthood [J].G Ital Cardiol. 1998, 28 (12): 1418-1421.
7Schmidt H, Schmidt R, Niederkorn K,et al. Beta-fibrinogen gene polymorphism (C148→T) is associated with carotid atherosclerosis, results of the Austrian Stroke Prevention Study [J]. Arterioscler Thromb Vase Bio1,1998,18(3):487-492.
8Knuiman MW, Folsom AR, Charnbless LE, et al. Association of hernostatic variables with MRI-deteted cerebral abnorrnalities:the atherosclersis risk in communities study [J]. Neuroepidemio,2001,20(2) : 96-104.
9Kroger K,Buss C. Risk factors in young patients with peripheral atherosclerosis [J]. Int Angiol, 2000,19 (3) :206-211.
10Honczarenko K, Torbus-Lisiecka B. Fibriongen and lipids: associated risk factors for ischemic cerebral stroke [J]. Neurol Neurochir Pol, 1999,33 (3) : 557-565.
